Expression of the myelin oligodendrocyte glycoprotein (MOG) gene, a target antigen for myelin-destructive antibodies in autoimmune CNS demyelinating diseases, such as multiple sclerosis, and a cell surface marker of oligodendrocyte maturation, was also significantly decreased in schizophrenia [38]. This evidence concerns the gene MOG and schizophrenia.